Under pathological conditions, the abnormal increase of ALCAT1 leads to the massive production of ROS, mitochondrial dysfunction, and insulin resistance [16–18], which is the core link of obesity [19], Parkinson's disease [20], diabetes [21], and other chronic diseases and aging process [22]. Here, LCLAT1 is linked to obesity disorder.